Literature DB >> 18501435

Enrichment of prion protein in exosomes derived from ovine cerebral spinal fluid.

Laura J Vella1, Deanne L V Greenwood, Roberto Cappai, Jean-Pierre Y Scheerlinck, Andrew F Hill.   

Abstract

Prion diseases are transmissible neurodegenerative disorders affecting humans and a wide variety of animal species including sheep and cattle. The transmissible agent, the prion, is an abnormally folded form (PrP(Sc)) of the host encoded cellular prion protein (PrP(C)). Distribution of the prion protein in the fluids of species susceptible to these diseases is of importance to human health and the iatrogenic spread of prion disease. Aside from blood which is confirmed to be a source of prion infectivity, it is currently unclear which other body fluids harbor a significant transmission risk. In the current study we examined two ovine fluids; pseudo-afferent lymph and cerebral spinal fluid (CSF), for the presence of exosomes and concurrent enrichment of the normal, cellular form of the prion protein (PrP(C)). Here we demonstrate the existence of exosomes in both pseudo-afferent lymph and CSF isolated from sheep. In the CSF derived exosomes we were able to show an enrichment of PrP(C) over unfractionated CSF. This experimental approach suggests that CSF derived exosomes could be used as a novel means of detecting abnormal forms of the prion protein and provide an in vivo link between these vesicles and prion disease pathogenesis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18501435     DOI: 10.1016/j.vetimm.2008.04.002

Source DB:  PubMed          Journal:  Vet Immunol Immunopathol        ISSN: 0165-2427            Impact factor:   2.046


  94 in total

1.  Candidate biomarkers in exosome-like vesicles purified from rat and mouse urine samples.

Authors:  Javier Conde-Vancells; Eva Rodriguez-Suarez; Esperanza Gonzalez; Agustin Berisa; David Gil; Nieves Embade; Mikel Valle; Zigmund Luka; Felix Elortza; Conrad Wagner; Shelly C Lu; Jose M Mato; M Falcon-Perez
Journal:  Proteomics Clin Appl       Date:  2010-04       Impact factor: 3.494

Review 2.  Exosomes: mediators of neurodegeneration, neuroprotection and therapeutics.

Authors:  Anuradha Kalani; Alka Tyagi; Neetu Tyagi
Journal:  Mol Neurobiol       Date:  2013-09-03       Impact factor: 5.590

3.  First demonstration of transmissible spongiform encephalopathy-associated prion protein (PrPTSE) in extracellular vesicles from plasma of mice infected with mouse-adapted variant Creutzfeldt-Jakob disease by in vitro amplification.

Authors:  Paula Saá; Oksana Yakovleva; Jorge de Castro; Irina Vasilyeva; Silvia H De Paoli; Jan Simak; Larisa Cervenakova
Journal:  J Biol Chem       Date:  2014-08-25       Impact factor: 5.157

Review 4.  Emerging roles of extracellular vesicles in neurodegenerative disorders.

Authors:  Yang You; Tsuneya Ikezu
Journal:  Neurobiol Dis       Date:  2019-06-20       Impact factor: 5.996

Review 5.  Exosomes: a new weapon to treat the central nervous system.

Authors:  Luca Braccioli; Cindy van Velthoven; Cobi J Heijnen
Journal:  Mol Neurobiol       Date:  2013-07-16       Impact factor: 5.590

6.  Cell-specific uptake of mantle cell lymphoma-derived exosomes by malignant and non-malignant B-lymphocytes.

Authors:  Inbal Hazan-Halevy; Daniel Rosenblum; Shiri Weinstein; Osnat Bairey; Pia Raanani; Dan Peer
Journal:  Cancer Lett       Date:  2015-04-28       Impact factor: 8.679

7.  Do Neural Cells Communicate with Endothelial Cells via Secretory Exosomes and Microvesicles?

Authors:  Neil R Smalheiser
Journal:  Cardiovasc Psychiatry Neurol       Date:  2009-08-03

Review 8.  Lysosomal Quality Control in Prion Diseases.

Authors:  Priyanka Majumder; Oishee Chakrabarti
Journal:  Mol Neurobiol       Date:  2017-04-18       Impact factor: 5.590

Review 9.  The role of exosomes in allograft immunity.

Authors:  Sandhya Bansal; Monal Sharma; Ranjithkumar R; T Mohanakumar
Journal:  Cell Immunol       Date:  2018-06-07       Impact factor: 4.868

Review 10.  Protease resistant protein cellular isoform (PrP(c)) as a biomarker: clues into the pathogenesis of HAND.

Authors:  Bezawit Megra; Eliseo Eugenin; Toni Roberts; Susan Morgello; Joan W Berman
Journal:  J Neuroimmune Pharmacol       Date:  2013-04-25       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.